🇺🇸 FDA
Pipeline program

SPD503 (Guanfacine hydrochloride)

SPD503-307

Phase 3 small_molecule completed

Quick answer

SPD503 (Guanfacine hydrochloride) for ADHD is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
ADHD
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials